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SUMMARY 
Development of antimicrobial resistance is internationally recognized as a major concern to 
public health and veterinary medicine. Methicillin-resistant Staphylococcus aureus (MRSA) 
and Methicillin-resistant Staphylococcus pseudintermedius (MRSP) can cause a variety of 
diseases and have limited options for treatment. Studies on the occurrence and prevalence of 
MRSA in cattle on the African continent are few, and reports of MRSP are even fewer. This 
pilot study hoped to shed some light on how widespread antibiotic resistance in S. aureus and 
S. pseudintermedius might be in animals in Kampala. 
The study included (a) 26 samples from commercially sold raw milk, (b) 66 samples of fresh 
milk pooled with nasal and perineal swabs from dairy cattle, and (c) 40 nasal and perineal swabs 
from dogs. After enrichment in selective broth, S. aureus was isolated from (a) five, (b) tree 
and (c) five of the samples respectively, and S. pseudintermedius was isolated from ten of the 
dog samples. One MRSA was identified from the (a) raw milk category, according to 
phenotypic characteristics, but the genes mecA or mecC PCR could not be amplified on Real-
Time PCR. All ten isolated S. pseudintermedius had MICs < 0.25 μg/mL for oxacillin, and 
where thus not regarded as MRSP, but three isolates were resistant to ≥ 3 classes of antibiotics, 
thus these isolates might be regarded as multi-drug resistant. The results warrant further 
investigations to establish the prevalence of these bacteria. 
 
SAMMANFATTNING 
Utveckling av antibiotikaresistens är ett internationellt allvarligt problem inom både human- 
och veterinärvården. Meticillin-resistenta Staphylococcus aureus (MRSA) och Meticillin-
resistenta Staphylococcus pseudintermedius (MRSP) kan orsaka en mängd olika sjukdomar och 
har i vissa fall få behandlingsalternativ. Studier kring förekomst och prevalens av MRSA hos 
nötkreatur från den afrikanska kontinenten är få, och rapporter om MRSP är ännu färre. Vi ville 
med denna pilotstudie få en uppfattning om hur utbredd antibiotikaresistens är hos isolat av S. 
aureus och S. pseudintermedius från djur i Kampala. 
I studien ingick (a) 26 prover tagna från opastöriserad mjölk såld i området, (b) 66 prover från 
noshåla, perineum och mjölk från mjölkkor och (c) 40 svabbprover från nos och perineum på 
hundar. Efter anrikning i selektiv buljong kunde S. aureus isoleras från (a) fem, (b) tre och (c) 
fem prover i respektive kategori och från tio av hundarna isolerades S. pseudintermedius. Från 
den förstnämnda kategorin (a) med mjölkprover isolerades en fenotypisk MRSA, där generna 
mecA eller mecC dock inte kunde påvisas. Alla tio isolerade S. pseudintermedius hade MIC < 
0,25 μg/mL för oxacillin, vilket betyder att ingen definierades som MRSP men tre isolat 
uppvisade resistens mot ≥ 3 antibiotikaklasser, vilket gör att de kan betraktas som 
multiresistenta. Dessa resultat lägger en grund för vidare studier rörande prevalensen av dessa 
bakterier. 
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INTRODUCTION 
The population of Uganda is one of the world’s fastest growing and youngest, and also one of 
the world’s poorest when counted as GDP (gross domestic product) per capita. The population 
is estimated (Jul 2017) to be 39 million and out of these about 25% is undernourished and 6.5% 
living with HIV/AIDS. With the majority of people living in rural areas, agriculture is the most 
important source of livelihood for a large proportion of the Ugandan population (FAOSTAT; 
CIA, 2018). The most commonly held domesticated mammals are goats with an estimate of 
12.5 million heads in a census in 2008, followed by cattle at 11.4 million and sheep at 3.4 
million. Dogs were in the same census estimated to be 1.6 million (UBOS, 2010). Dogs in 
Uganda have traditionally been kept for hunting, herding, security and guarding livestock 
(Millán et al., 2013). Many tropical diseases are still common in cattle, and these are often 
treated with antibiotics (UNAS, 2015). 
Development of antimicrobial resistance is internationally recognized as a major concern to 
public health. Highlighting its importance, antimicrobial resistance was raised as a topic for the 
UN General Assembly in Sept 2016, as one of only four subjects relating to a public health 
problem ever to be lifted in this way (PRESS RELEASE: High-Level Meeting on Antimicrobial 
Resistance, 2016). The prevalence of different antibiotic-resistant strains of bacteria in various 
countries of Africa has been shown to be intermediate to high, but the studies are relatively few, 
as in many developing countries (Rothe et al., 2013; Abdulgader et al., 2015; Lozano et al., 
2016; Najjuka et al., 2016; Pires Dos Santos et al., 2016). The studies published on Methicillin-
resistant Staphylococci in Uganda have almost exclusively been related to human healthcare 
(Asiimwe et al., 2017b) and to our knowledge, none has been done on Methicillin-resistant S. 
pseudintermedius (MRSP). 
This pilot study aimed to investigate the presence of Methicillin-resistant S. aureus (MRSA) or 
MRSP in dogs, cattle and milk in Kampala, by definition of phenotype or by presence of the 
genes mecA or mecC.  
  
2 
 
LITERATURE REVIEW 
Conditions for animals and animal industry in Uganda 
The dairy industry in Uganda 
Cattle are the major milk-producers in Uganda and an average cow produces 8.5 L of milk per 
week. Uganda has five geographical regions, whereof the central and western regions have both 
the highest number of milked cows and the highest milk yield per cow. These regions also have 
the highest percentage of and are suitable for temperate cow breeds such as the Holstein-
Friesian. These breeds or crossbreeds produce about 30% of the total milk produced in Uganda 
and have a 2-3 times higher average milk-yield per cow than the indigenous breeds such as 
Ankole. Still, indigenous cows yield most of the milk produced in Uganda. They are more 
resistant to diseases (e.g. spread by the tsetse-fly), adaptable to local conditions and are more 
versatile, also producing beef, draft power and various social functions (Balikowa, 2011; UBOS 
2010). 
The dairy cows in Uganda are mostly kept in intensive farming systems in the urban and peri-
urban settings. In the rural settings the extensive systems are prevailing and are largely based 
on small herds, mostly managed by family members. Intensive systems require a higher input 
e.g. hired labour, food or AI-services, but generally also generate higher output and larger herds. 
A recently expanding sector that is an exception to this are the zero-grazing smallholder farms 
where 1-3 dairy cows are kept in enclosures and fed concentrates and grass or parts from cash 
crops (Garcia et al., 2008). In total, smallholder producers own over 90% of the national herd 
and the average herd is only 6.9 cows (UBOS, 2010; UNAS, 2015). Milk is mostly produced 
in the so-called “cattle-belt” extending from South-western to Central Uganda. The Kiruhura 
and Mbarara region in South Western Uganda produces a significant part of the national milk 
production (Mwebaze & Kjaer, 2013). In these areas, the dominating production types are 
pastoral or agro-pastoral, the latter being semi-intensive (Grimaud et al., 2007a). 
The milk in Uganda is sold either through the formal or informal market. The formal market 
includes large-scale processing companies, which place strict quality controls both on the raw 
milk and on the processing, usually including pasteurization and packing. The informal market 
constitutes an estimated 87% of the marketed milk in Uganda and most of this milk is sold 
without previous processing or packaging (Balikowa, 2011). Farmers are, according to numbers 
from the 2008 national census, only selling approximately 35% of the milk they produce, thus 
the producing household is consuming most of the product (UBOS, 2010). In the Mbarara 
region 85.7% of the respondents stated that they consumed milk at least once a day and 37.9% 
consumed it without previous boiling (Nasinyama et al., 2014). Both figures were slightly lower 
in the Kampala region, with 53.6% consuming milk daily and 16.7% reporting consumption of 
unboiled milk (Nasinyama et al., 2014). Another study found consumption of raw milk in 15% 
of the respondents in Gulu district, Northern Uganda, and 42% of the respondents in Soroti 
district, Eastern Uganda (Rock et al., 2016). The milk can be sold directly from the farm, to 
nearby households or to milk collection centres, sometimes through a chain of middlemen. 
From the milk collection centres, the milk can be sold to consumers or be collected for transport 
in insulated road tankers and distributed among milk collection centres in urban areas, for 
example Kampala (Balikowa, 2011).  
Most farmers rely on hand milking, milking machines are rare and milking hygiene is often of 
substandard quality (Kateete et al., 2013). The base levels of contamination on the farms is 
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unacceptably high and according to one study, total plate count (TPC) was around 2 × 106 
colony forming units per millilitre (cfu/mL) in the dry season and 8 × 106 cfu/mL in the rainy 
season (Grimaud et al., 2009). By the time the milk reached the milk collecting centre (in 
Mbarara) the TPC was around 83 × 106 cfu/mL and when it reached the urban market in 
Kampala the value was 1419 × 106 cfu/mL in the dry season and 953 × 106 cfu/mL in the rainy 
season (Grimaud et al., 2009). However, some uncertainty exists regarding these figures, since 
in an earlier publication Grimaud et al. (2007b) stated that the study was conducted in 2004, 
before the 2006 ban on long-range transport of milk in aluminium cans (Mwebaze & Kjaer, 
2013). However, another study found TPC to be 245-324 × 106 cfu/mL in milk from milk 
cooling points in central Kampala (Mugampoza et al., 2011) and a Kenyan study stated similar 
figures of 117 × 106 cfu/mL in raw can milk on arrival to the first milk collection centre 
(Teresiah et al., 2016). Another Kenyan study found that most milk had < 2 × 106 cfu/mL at 
the farm level but 43-70% of milk sold had > 2 × 106 cfu/mL (Orregård, 2013).  
As a reference value, most Swedish farms are consistently delivering milk with less than 15 
000 cfu/mL (Christiansson et al., 2011) and according to the European Commission regulation 
(EC) No 1020/2008 of 17 October 20081, actions must be made to ensure that the total plate 
count is under 300 000 cfu/ml in raw cows’ milk used to prepare dairy products. Acceptable 
microbial standards for raw milk according to East African Standards are < 2 × 106 cfu/mL for 
TPC in raw milk (EAS 67:2006). 
The Dairy Development Authority, Uganda requires registration and annual registration fees 
from all individuals and companies intending to handle or process milk, a practice that was 
established to enable them to carry out inspections (Dairy Development Authority). To increase 
profits, however, many farmers and vendors still add water to the milk, a claim that can be 
validated by abnormally low density in 30-36% of milk samples in urban milk coolers and up 
to 86% of milk from cyclist mobile vendors (Balikowa, 2011; Grimaud et al., 2009). Again, 
Kenyan studies show similar numbers, with unacceptably low density in 27% (Orregård, 2013) 
or 23.8%-36.8% (Teresiah et al., 2016) of samples at shop level. Against regulations, to 
counteract the contamination of the milk, milk is sometimes boiled in large open metallic 
containers or various chemicals are added to the milk (Balikowa, 2011). 
Dog ownership in Uganda 
Information portraying dog ecology or management in Uganda has seldom been captured in 
studies, but a study including 799 respondents identifying 175 dog owners in five districts 
distributed from Western to Eastern Uganda reported that 31.4% of the dogs were always 
allowed to roam freely, whereas 21.7% were always confined to the owner’s property. Overall 
74.3% of the dogs were allowed to roam freely to some degree. Less than half of the owners 
provided their dogs with veterinary care (43.7%) or shelter (37.9%). Based on stated number 
of deaths during the last five years, the rate of suspected canine rabies was 5.1 per 1000 dogs 
per year and the mortality rate was 101 deaths per 1000 dogs per year. In this study the number 
of unowned dogs in the villages could not be ascertained and these dogs were thus not included 
(Wallace et al., 2017). A cohort study following 61 dogs during fifteen months in rural Western 
Uganda, showed that crude mortality rate was 168 per 1000 dogs per year, with infectious 
disease causing 46.1% of the deaths, followed by culling (euthanasia) performed by the owners 
(30.8%), and attacks by baboons, Papio anubis (23.1%). Interviews indicated that 98.4% of the 
                                                     
1) OJ L 277/8, 18.10.2008, p. 7, Celex 32008R1020. 
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dogs were fed human food and most dogs also hunted or scavenged wildlife and ate dead 
livestock at least once a year. Over half (54.1%) had poor body condition score (< 2/5) and all 
interacted daily with other dogs (Hyeroba et al., 2017).  
Suburban areas of developing countries generally have a higher dog density but lower dog-to-
human ratios as compared to rural areas (Davlin & VonVille, 2012). The overall dog-to-human 
ratio in Africa has been estimated at 1:21 in urban areas and 1:7 in rural areas (Knobel et al., 
2005) but Wallace et al. (2017) claims that the dog-to-human ratio in Uganda is probably better 
estimated as almost the double (1:47) since he found that poverty affects the likelihood of dog-
ownership. With this consideration he estimates the Ugandan dog population to include 729 
486 dogs. 
Diseases of the cattle and their treatment 
Common diseases in Ugandan cattle include Foot-and-Mouth-disease and Contagious Bovine 
Pleuropneumonia. East Coast Fever is a substantial problem in some areas and other tick- borne 
diseases like Lumpy Skin Disease are also frequent. Further, mastitis and subclinical mastitis 
are common, and cause significant loss of milk production and profits (UNAS, 2015). In a 
worldwide perspective, mastitis is the most prevalent disease in the dairy industry. It has severe 
economic impact through decrease in milk production, drug- and veterinary costs and 
sometimes by premature culling of cows (Seegers et al., 2003). 
Mastitis is by definition inflammation of the mammary glands. It can manifest itself as anything 
from a severe, systemic illness to a mild inflammation that only affects the quality of the milk. 
Clinical mastitis (CM) is diagnosed when the milk looks abnormal and/or the animal displays 
signs of infection or inflammation of the udder. Subclinical mastitis (SCM) cannot be found 
through a physical examination and is usually diagnosed through an elevated somatic cell count 
(SCC; more than 200 000 cells/mL) in the milk. Infection, tissue injury or stress to the 
mammary gland results in an increase of both epithelial cells and leucocytes (mostly 
neutrophils), modulated by inflammatory mediators. However, SCC is affected by e.g. the stage 
of lactation, breed, time of the day and season, and there is an overlap between SCC-values of 
the normal and the infected udder. Milk with high SCC has altered properties which results in 
reduced cheese yield and can disrupt fermentation processes (e.g. of yogurt). Causative 
infective agents are frequently also a zoonotic concern, through viable organisms or their toxins 
in the milk (Harmon, 1994; Sharma et al., 2011). 
In a survey on subclinical mastitis in the Kiboga district located in central Uganda, 87.9% of 
the 124 dairy cattle from 12 farms suffered from subclinical mastitis. Over half of the cows 
(54.8%) were affected in all four quarters whereas 4% of the cows were negative in all quarters. 
Out of 163 isolates, the most commonly isolated bacteria were coagulase-negative 
staphylococci (64.4%) and S. aureus (16.6%) (Kasozi et al., 2014). Byarugaba (2008) reports 
a lower frequency of 60.7% cases of subclinical mastitis in the eastern district of Jinja, with 
bacteria isolated in 51.9% of 688 quarter samples. The most commonly isolated bacteria in this 
study were coagulase-negative staphylococci, coliforms and S. aureus (Byarugaba, 2008). In 
the Kiruhura district, southwestern Uganda, a study found subclinical mastitis in 76.1% out of 
71 cows tested, with Staphylococcus spp. isolated in 30.8%. Proteus spp. was the next most 
commonly found bacteria with a prevalence of 13.8% (Ssajjakambwe et al., 2017). A study 
looking at clinical mastitis in the Kampala area identified 20 out of 58 (34.5%) strains to be 
coagulase negative staphylococci (CNS), 12 (20.7%) strains to be E. coli and only one (2%) to 
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be S. aureus. The most commonly found CNS strains were S. saphrophyticus, S. xylosus and S. 
sciuri (Kateete et al., 2013).  
Another study on subclinical mastitis in the urban and suburban region of Kampala showed that 
using the California mastitis test (CMT), 86.2% of 195 tested cattle had ≤ 3 in at least one 
quarter. This study found coagulase-negative staphylococci to be the most commonly isolated 
bacteria, and isolated S. aureus in 8 (0.9%) cases. In this study, all clinical cases of mastitis 
were excluded (Abrahmsén et al., 2014). A complementary study in the same area reported 
clinical mastitis in 13% and CMT ≤ 3 in at least one quarter in 90% of the 138 cows tested. 
Bacteriological sampling of all quarters with CMT ≤ 4 revealed the most prevalent cause of 
clinical and subclinical mastitis to be coagulase-negative staphylococci, of which S. epidermidis 
was the most commonly isolated. S. aureus were isolated in 8.5% of the clinical and 4% of the 
subclinical cases of mastitis (Björk, 2013).  
A thesis study on milk quality in South-western Uganda reported the average SCC in milk from 
100 farms to be 507 000 cells/mL, with 34% of the farms being under 200 000 cells/mL and 
7% being over 1000 000 cells/mL (Rutaro, 2015). All the Ugandan studies judged SCC 
according to scores described by Mellenberger & Roth (2008), where a score of  “one” or more 
is considered sublinical mastitis and “three” is the maximum score. Abrahmsén et al. (2014) 
and Björk (2013) judged subclinical mastitis according to the Nordic grading system where 
“three” roughly corresponds to score “one” according to Mellenberger & Roth (2008; Table 1). 
Table 1. The two grading systems used for studies on subclinical mastitis and their corresponding 
SCC/mL 
Interpretation 
Mellenberger 
& Roth 
Corresponding 
SCC/ml 
Nordic 
System Corresponding SCC/ml 
Negative  N 100 000 1 0 - 200 000 
Trace  T 300 000 2 150 000 - 500 000 
Weakly positive  1 900 000 3 400 000 - 1 500 000 
Positive  2 2.7 million 4  800 000 - 5 000 000 
Strongly positive  3 8.1 million 5 > 5 000 000  
 
Many authors relate the high frequency of mastitis on Ugandan farms to poor milking hygiene 
and absence of milking order in relation to udder health status (Byarugaba, 2008; Kateete et al., 
2013; Abrahmsén et al., 2014; Björk et al., 2014; Ssajjakambwe et al., 2017) and some authors 
also relate it to the suboptimal use of antibiotics (Byarugaba, 2008; Kateete et al., 2013; Kasozi 
et al., 2014; Ssajjakambwe et al., 2017). The most commonly used antibiotics were penicillin 
and tetracycline (Byarugaba, 2008; Kateete et al., 2013; Kasozi et al., 2014; Ssajjakambwe et 
al., 2017), an observation that is true for the veterinary sector at large in Uganda (UNAS, 2015).  
Antibiotic usage in agriculture in Uganda is legally only permitted after prescription from 
veterinary surgeons, but the authorities’ means for control are insufficient and most antibiotics 
are readily available over-the-counter for anyone in community pharmacies (Mukonzo et al., 
2013). Sales numbers are thereby hard or impossible to estimate. Usage of tetracycline in the 
vaccination procedure for Theileria parva Lawrencei described by Radley et al. (1979) is still 
widely practiced in Uganda (Perry, 2016). Knowledge of the accelerators of antibiotic 
resistance is low, and even students in health sciences are not using it appropriately (Nambatya 
et al., 2011). 
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Antibiotic resistance 
It is important to remember that usage of antibiotics against one pathogen is not only selecting 
for resistance in that specific pathogen, but also in all other bacteria exposed. Every time an 
antimicrobial agent is used it will select for overgrowth of bacteria that expresses genes for 
resistance towards that agent. Resistant strains will have less competition and can multiply with 
great speed. Since they might not cause disease, commensals that become resistant are likely to 
be selected and maintained without detection, giving them ample opportunity to serve as 
reservoirs of resistance genes (O’Brien, 2002).  
Antibiotic resistance can be intrinsic, a natural quality in the organism in absence of selective 
pressure of antibiotics (Sefton, 2002). Of greater consequence is the acquired resistance, where 
the genome of the bacteria is altered either by spontaneous mutations and selection or by 
acquisition of extrinsic DNA (Sefton, 2002; Tenover, 2006). The three main mechanisms of 
gene transfer between microorganisms are conjugation of plasmids, transformation and 
bacteriophage transduction. In short, transduction occurs when bacteriophages (viruses that 
infects bacteria) accidentally carry bacterial genes between bacterial hosts and transformation 
may occur when a bacterium encounters free DNA in the environment and incorporates it into 
its chromosome (Holmes et al., 2016). Plasmids are circular DNA mobile genetic elements that 
can transfer directly between two bacteria through a pore or tube connecting the two bacterial 
cells. Plasmid conjugation is the most efficient way of horizontal gene transfer and is considered 
one of the major reasons for spread of antibiotic resistance (Grohmann et al., 2003). 
The natural resistance of bacteria can be referred to as the “wild type” of that bacteria. The 
natural resistance of a bacterial species is relevant in the determination of epidemiological cut-
off values (ECOFFs) for resistance, which are used in this study. The ECOFF value is not 
necessarily equivalent to the clinical resistance breakpoint, and an ECOFF value for a certain 
antibiotic in a bacterium that is naturally sensitive to that antibiotic can thus be lower than the 
MIC that is considered as clinical resistance (Swedres-Svarm, 2016). 
In staphylococci, there are two different resistance mechanisms that mainly account for β-
lactam resistance. It is achieved either through enzymatic inactivation by β-lactamase, or target 
site replacement by the gene products of mec-genes, coding for alternative penicillin-binding 
proteins that have a strongly reduced affinity to virtually all β-lactam antibiotics (McManus, 
1997; Wendlandt et al., 2015). Staphylococcus aureus, Staphylococcus pseudintermedius and 
coagulase-negative staphylococci can all carry mec-genes and are considered commensals with 
pathogenic potential (Piette & Verschraegen, 2009; Feßler et al., 2010; Weese & van Duijkeren, 
2010; Bannoehr & Guardabassi, 2012). 
Staphylococcus aureus 
Characteristics 
S. aureus is a common coloniser of human and animal epithelia and may act as an opportunistic 
pathogen, often involved in skin and soft tissue infections (Grundmann et al., 2006; Bouchiat 
et al., 2017; Planet et al., 2017). It commonly expresses a variety of different toxins and 
virulence factors that enable it to invade tissues and evade the immune system ( Wamel et al., 
2006; Thammavongsa et al., 2015). One of these is Panton-Valentine leucocidin (PVL), a two-
component pore-forming toxin targeting human and rabbit mononuclear cells (Prévost et al., 
1995). It is encoded by the genes lukS-PV and lukF-PV and is transferred through 
bacteriophages (Boakes et al., 2011). It has been linked by epidemiological data to invasive 
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disease in people without previous healthcare-contact (Lina et al., 1999; Gillet et al., 2002) but 
the extent to which the presence of the gene affects virulence is not clearly established (Voyich 
et al., 2006; Boyle-Vavra & Daum, 2007; Malachowa et al., 2011; van Hal et al., 2012). An 
association between leukocidins and severity of bovine mastitis has also been suggested (Bar-
Gal et al., 2015). In bovine mastitis, different strains show distinct pathogenic, contagious and 
persistence traits, and may thus require different strategies of control and treatment (Fournier 
et al., 2008; Graber et al., 2009; Harris et al., 2013; Wang et al., 2017).   
Different lineages of S. aureus generally show a certain degree of host specificity (Sung et al., 
2008). The differences were however found to be small, with genes between animal and human 
lineages showing no larger differences as compared to the differences in genes between animal 
lineages. Strains isolated from bovine mastitis were most commonly found to be native to the 
species, whereas other animals like horses and dogs were more often considered transient 
carriers, since strains isolated tended to originate from human lineages (Sung et al., 2008). 
Other studies have found that human-bovine host shift can occur (Sakwinska et al., 2011), that 
a bovine S. aureus strain was as capable of colonising and persisting in human nares as a human-
native strain (Slingerland et al., 2012) and when co-colonising gnotobiotic piglets, a human-
native and a porcine-native strain were growing in equal densities (McCarthy et al., 2014). 
Identical or near identical strains have also been isolated from humans and animals that live in 
close proximity, suggesting transfer of bacterial strains (Voss et al., 2005; Weese et al., 2006). 
Different bacterial species vary greatly in the stability of the genome (from clonal to 
recombinogenic), and S. aureus displays a very clonal population structure (Vos & Didelot, 
2009). Lineages are divided into clonal complexes (CCs) of strains with similar multilocus 
sequence types (MLSTs) or sometimes groups of CCs on an epidemiological basis (Haaber et 
al., 2017). Another way of identifying related S. aureus-strains is spa-typing, where a variable 
region of the surface protein A is genotyped (Miao et al., 2017). The mobile genetic elements 
(MGEs) comprise 15-20% of the genome in S. aureus (Haaber et al., 2017) and the most 
common MGEs are bacteriophages, pathogenicity islands (SaPI), transposons, plasmids and 
staphylococcal cassette chromosomes (SCC) (Lindsay, 2010). All these elements may carry 
and transfer antibiotic resistance genes (Haaber et al., 2017).  
β-lactam-resistance in S. aureus 
The first antibiotic widely used against staphylococci was penicillin. It binds to a penicillin-
binding protein in the bacterial cell wall and ultimately kills the microbe. It was introduced in 
the 1940s and soon some strains were observed to resist the antibiotic. The cause of the 
resistance was identified as the production of penicillinases or β-lactamases, enzymes that can 
break down the β-lactam ring of penicillin (Kirby, 1944; Abraham et al., 1941). Methicillin was 
the first semisynthetic penicillin and had an increased resistance towards β-lactamases 
(Grundmann et al., 2006). Cephalosporin antibiotics are even more resistant to β-lactamases, 
although some β-lactamases have an increased affinity for cephalosporins (Bush & Jacoby, 
2010). 
Methicillin-resistant S. aureus (MRSA) was first identified in the early 1960’s just two years 
after the introduction of Methicillin on the market (Jevons, 1961). The earliest described 
mediator of the broad β-lactam resistance that is associated with the methicillin-resistant strains 
of S. aureus is the gene mecA (Matsuhashi et al., 1986), borne on a staphylococcal cassette 
chromosome mec (SCCmec) mobile genetic element. This gene induces changes in the bacterial 
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target of β-lactam antibiotics, the penicillin binding protein PB2, and dramatically diminishes 
its affinity for all β-lactam antibiotics (Hartman & Tomasz, 1981; Pinho et al., 2001). 
At first the strains isolated were primarily found in connection to human healthcare (Jack 
Benner & Kayser, 1968; Rountree & Beard, 1968; Grundmann et al., 2006). These first strains 
became known as Healthcare associated/acquired (HA) MRSA when in the late 1990’s, the 
community-associated/acquired (CA) MRSA started emerging (Herold et al., 1998; Okuma et 
al., 2002; Vandenesch et al., 2003). These new CA-MRSA strains were isolated from humans 
without any apparent previous contact or connection to the healthcare system (Herold et al., 
1998; Stefani et al., 2012). In the mid-late 2000’s when livestock-associated (LA) MRSA 
strains were found in quick succession, it became evident that this also was a serious problem 
from the veterinary and OneHealth perspective (Voss et al., 2005; van Loo et al., 2007; Weese 
& van Duijkeren, 2010). Though, as strains of different clonal complexes are found in new 
settings, these associations are blurring (Bal et al., 2016). 
The gene mecALGA251, later renamed mecC (Ito et al., 2012), was characterized in 2011 but has 
been found in clinical samples with origin from decades earlier (García-Álvarez et al., 2011; 
Shore et al., 2011). Thus, many samples and cases have potentially been missed or 
misdiagnosed (Guardabassi et al., 2013; Paterson et al., 2014). mecC is 70% homologous to 
mecA on a gene- and amino acid level (García-Álvarez et al., 2011) but, interestingly, a slight 
difference in antibiotic resistance has been observed between the phenotypes associated with 
carriage of the two genes. The strains expressing mecA are most commonly resistant to both 
oxacillin and cefoxitin, while the strains expressing mecC are often relatively sensitive to 
oxacillin but resistant to cefoxitin. Therefore, cefoxitin is considered a better determinant of 
possible MRSA-strains as compared to oxacillin (Kim et al., 2012; Skov et al., 2014).  
The provenance of the mecA genes is not yet known, however several studies have found mecA 
homologs in animal commensals like Staphylococcus sciuri (Couto et al., 1996; Wu et al., 2001; 
Monecke et al., 2012; Harrison et al., 2014), Staphylococcus fleurettii (Tsubakishita et al., 
2010; Monecke et al., 2012), Staphylococcus haemolyticus (Monecke et al., 2012) and 
Macrococcus caseolyticus (Baba et al., 2009; Tsubakishita et al., 2010; Gómez-Sanz et al., 
2015; Schwendener et al., 2017). However, not all are associated with β-lactam resistance 
(Monecke et al., 2012). Some of these mecA homologs have been proposed as the mecA-
precursor (Couto et al., 1996; Wu et al., 1996; Rolo et al., 2017). A recent study indicates that 
β-lactams and antibiotics that target DNA (e.g. trimethoprim and ciprofloxacin) can trigger a 
SOS-mechanism that promotes SCCmec-excision and thereby enable horizontal gene transfer 
(Liu et al., 2017). In the absence of stressors, these excisions still occur but at a very low rate 
(Stojanov et al., 2013; Liu et al., 2017). There is evidence that SCCmec-elements have been 
exchanged between S. epidermidis and S. aureus (Wielders et al., 2001; Méric et al., 2015) and 
it has been proposed that mecA originated from coagulase-negative staphylococci, and was 
transferred through S. epidermidis to S. aureus (Méric et al., 2015; Haaber et al., 2017). 
Transfer of mecB to S. aureus has however not been seen, until very recently when a S. aureus 
carrying mecB was isolated (Becker et al., 2018). The isolate was recovered from a 67-year old 
cardiology inpatient with no signs of infection, during routine MRSA screening in Germany. 
The mecB was identical (100% complete sequence identity) to mecB earlier found in M. 
caseolyticus (Baba et al., 2009; Tsubakishita et al., 2010; Becker et al., 2018) either within an 
SCCmec-like element or carried on a plasmid (Baba et al., 2009; Tsubakishita et al., 2010; 
Gómez-Sanz et al., 2015). This S. aureus carried the mecB on a plasmid distantly related to the 
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one seen in M. caseolyticus, supporting possible gene transfer between the genera. Carriage on 
a plasmid has the potential to increase transferability of the methicillin resistance and drastically 
change the MRSA epidemiology (Becker et al., 2018).  
The prevalence of MRSA in EU/EEA countries is ranging between 1.2% and 50.5%, with the 
northern countries in general reporting the lower frequencies. A decreasing trend has been 
observed in more than a third of the countries between the years 2013-2016. Comprehensive 
MRSA strategies, regarding both prudent antimicrobial use and infection prevention and 
control across all healthcare sectors, remain essential to further slow the spread (ECDC, 2016).  
Transfer and spread of resistance in S. aureus 
As earlier mentioned, S. aureus displays a very clonal family tree (Vos & Didelot, 2009). 
Several barriers for gene transfer exists; The type I restriction-modification system (Waldron 
& Lindsay, 2006; Sung et al., 2008; Cooper et al., 2017) and type IV restriction systems 
(Corvaglia et al., 2010; Xu et al., 2011) are very effective and common and the CRISPR-cas-
system are also present but uncommon (Cao et al., 2016). There are differences in the 
restriction-modification systems between CCs, which has been proposed to underlie the 
findings that transfer within lineages rather than between lineages seem to be more common 
(Waldron & Lindsay, 2006; Roberts et al., 2013; Planet et al., 2017).  
The spread of resistant clones can also be limited by fitness of the clones, illustrated by reports 
of clones outcompeting and replacing endemic clones (Knight et al., 2012; Baldan et al., 2015). 
S. aureus can exist on abiotic surfaces for months to years (Kramer et al., 2006) and therefore 
clones that acquire genes that make them more successful at surviving on surfaces might spread 
more easily (Baldan et al., 2015; Planet et al., 2017). Fitness in relation to the survival on or in 
the host can be illustrated by bacteriophages that carry human-specific immune-evasion genes 
and that have been associated with human rather than animal isolates (Wamel et al., 2006; Sung 
et al., 2008). The largest SCCmec-element have also proven to affect fitness (Ender et al., 2004) 
but others do not appear to have a fitness cost (Lee et al., 2007; Knight et al., 2013). 
Interestingly, the mechanism of transfer of the SCCmec-elements between staphylococci 
remains unknown (Haaber et al., 2017). Yet, the elements are widely dispersed in the genera 
(Haaber et al., 2017) and mobile SCCmec-elements may be imported more frequently by 
different S. aureus clonal lineages than previously thought, judging from frequent emergence 
of new clones with limited geographic dispersal observed in global collections of isolates 
(Nübel et al., 2008) and regional distribution of MRSA lineages in hospital settings in Europe 
(Grundmann et al., 2010). The variance in spa-types and SCCmec-elements of non-Methicillin 
resistant S. aureus lineages is still far greater (Grundmann et al., 2010; Becker et al., 2017) but 
genome analysis suggests that some mobile genetic elements may even cross species 
boundaries, represented by the likely acquisition of vancomycin resistance from enterococci 
(Noble et al., 1992; Weigel et al., 2003; Zhu et al., 2008; Rossi et al., 2014).  
Within lineages, in a co-colonisation model using gnotobiotic piglets, McCarthy et al. (2014) 
revealed horizontal gene transfer within just four hours. The study lasted a total of 16 days and 
notably, the strains co-cultured in vitro showed a considerably lower frequency of horizontal 
gene transfer than the in vivo strains (McCarthy et al., 2014). In a co-colonisation model in 
nares of human volunteers, the bovine S. aureus strain 5062 (CC398) and human S. aureus 
strain 1036 (CC8), showed no horizontal gene transfers (Slingerland et al., 2012), which 
McCarthy et al. (2014) postulates owed to that they were of different clonal complexes. Another 
recent study showed great inter-host variability of mobile genetic elements and antimicrobial 
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resistance in screened human patients in London, UK, with isolates of variable profiles isolated 
on a single sample occasion. Out of 38 MRSA carriers, only one carried isolates from different 
CCs. The results thereby were consistent with the piglet-colonisation model and suggested 
frequent horizontal gene transfer within lineages. It also puts the accuracy of antibiotic 
resistance profiles of other studies that only analyse a small number of colonies per sample in 
some uncertainty (Stanczak-Mrozek et al., 2015). 
Staphylococcus pseudintermedius 
Characteristics and resistance genes 
S. pseudintermedius is an opportunistic pathogen and the most prevalent cause of canine 
bacterial infections, but can also be found on cats and humans (Bannoehr & Guardabassi, 2012; 
McCarthy et al., 2014; Pires Dos Santos et al., 2016). S. pseudintermedius is part of the 
intermedius group, that used to be considered one species as they were indistinguishable 
phenotypically, but was characterized into three genera by molecular methods in 2007 (Sasaki 
et al., 2007). They are now referred to as S. delphini; originally isolated from dolphins, S. 
intermedius; most commonly isolated from pigeons, and S. pseudintermedius; most commonly 
isolated from dogs (Bannoehr et al., 2007; Sasaki et al., 2007). After this discovery, it was 
proposed that any studies that isolated S. intermedius from dogs before 2007 should be 
considered to have found S. pseudintermedius, unless genomic investigations proved otherwise 
(Devriese et al., 2009). 
S. pseudintermedius produces a wide array of virulence factors, of which many have functional 
and structural similarities to those of S. aureus (Lindsay, 2008). Alike S. aureus, it also seems 
to have acquired methicillin resistance through the gene mecA on multiple occasions (Bannoehr 
et al., 2007; Pires Dos Santos et al., 2016). Some clones of MRSP have spread with great 
success (Perreten et al., 2010; Ruscher et al., 2010) and are a big impediment in the treatment 
of infected dogs (Perreten et al., 2010; Weese & van Duijkeren, 2010; Kadlec et al., 2016), 
potentially causing a shift of antibiotics used towards off-label use of critically important human 
antibiotics (Weese & van Duijkeren, 2010). Prevalence of MRSP among S. pseudintermedius-
isolates from clinical cases varies considerably (Haenni et al., 2014; Kjellman et al., 2015; 
Grönthal et al., 2017; Ventrella et al., 2017; Worthing et al., 2018) and has been reported to be 
as high as 67% (Kawakami et al., 2010). 
Human infection with MRSP is rare (Van Hoovels et al., 2006; Stegmann et al., 2010; van 
Duijkeren et al., 2011), but may be overlooked by false identification in diagnostic laboratories, 
where the organism with some protocols gets misclassified as MRSA (van Duijkeren et al., 
2011; Guardabassi et al., 2013; Börjesson et al., 2015). Human carriage of S. pseudintermedius 
has been assumed to be unusual and transient (Weese & van Duijkeren, 2010) but varying 
degrees of S. pseudintermedius and MRSP-carriage in veterinarians or veterinary staff (Morris 
et al., 2010; Paul et al., 2011; Chanchaithong et al., 2014) and dog owners (Chanchaithong et 
al., 2014; Han et al., 2016) have been reported. A study in Thailand however reported that in a 
group without pet contact, no carriers of either S. pseudintermedius or MRSP were found, 
whereas 10.5% of veterinarians and 13% of owners carried MRSP (Chanchaithong et al., 2014). 
Reports of MRSP in Africa and South America are still too sparse to allow any conclusions to 
be drawn (Blunt et al., 2013; Quitoco et al., 2013; Pires Dos Santos et al., 2016).  
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Diagnosis  
Methods for isolation, determination of species and bacterial resistance 
Many different methods have been used in the aforementioned studies, both regarding the mode 
of sampling and for the choice of medium for culture, the method for antibiotic resistance 
determination, and the methods used for identification of bacterial species or studies on the 
epidemiological background. The latter includes genotyping methods such as Multilocus 
sequence typing (MLST), S aureus Protein A (spa) typing, Pulsed field gel electrophoresis 
(PFGE), Restriction fragment length polymorphism (RFLP), Whole-genome sequencing and 
SCCmec-typing (Miao et al., 2017).  
The most sensitive sampling site for S. aureus in humans (Armstrong-Esther & Smith, 1976) 
and horses (Bergström et al., 2013) is the nasal mucosa. In dogs, the nose is the second most 
common carrier-site for S. pseudintermedius and it is most reliably isolated by swabbing both 
the oral mucosa and the perineum (Bannoehr & Guardabassi, 2012). 
For cultivation, chromogenic agars have been developed to facilitate rapid and accurate 
screening for MRSA. These agars use colourless enzymes that are hydrolysed by MRSA to 
produce a visible colour-change in or around growing colonies (Xu et al., 2016). The 
chromogenic agar used in this study, BrillianceTM MRSA 2 agar, has been reported to have both 
high sensitivity (100%) and specificity (99.1%), when adding a broth enrichment step before 
the screening of clinical samples (Veenemans et al., 2013). Usage of enrichment broth before 
culturing has also been recommended in MRSP-screening, with subsequent culturing on blood 
agar being the most sensitive method (Saab et al., 2017). The protocol used in this study is 
closely adapted from the method used at the Swedish National Veterinary Institute (SVA) and 
the Swedish University of Agricultural Sciences (SLU). 
Using MLST and sequencing of the partial hsp60 gene respectively as the Gold standard, Matrix 
Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry has 
been recognised as a quick and reliable identification method for Staphylococci (Decristophoris 
et al., 2011; Murugaiyan et al., 2014). Both MLST (Quitoco et al., 2013; Haenni et al., 2014; 
Kjellman et al., 2015) and MALDI-TOF (Schwendener et al., 2017; Becker et al., 2018; 
Worthing et al., 2018) were used in several of the earlier mentioned studies.  
For detection of antibiotic resistance in S. aureus in veterinary medicine, the most commonly 
used phenotypic methods are agar diffusion and broth microdilution. Genotypic tests, like PCR 
screening for specific antibiotic resistance genes (e.g. mec-genes) can also be utilized. Agar 
disc diffusion utilizes paper discs infused with a known amount of antibiotics that are placed 
on agar plates where the bacteria that is to be tested has been evenly spread. The amount of 
bacteria on the plate, the time and temperature in the incubator etc. are predetermined and the 
antibiotics will diffuse out from the disc in the agar creating zones where the bacteria are 
inhibited from growing. These zones are measured and translated to levels of resistance 
(susceptible-intermediate-resistant) for the bacteria tested, with smaller zones equalling higher 
resistance. This method is cost-efficient but does not yield minimum inhibitory concentration 
(MIC) values for the antibiotics and standardisation can be problematic. Broth microdilution 
instead utilizes microtiterplates where the wells are lined with freeze-dried antibiotics in 
decreasing amounts. Two or three wells on each plate contain no antibiotics and serve as 
controls. Broth with a certain concentration of the bacteria that is to be tested is placed in each 
well, the wells are then sealed to prevent drying-off and incubated (in a predetermined time and 
12 
 
temperature). The antibiotics dissolve into the broth producing known concentrations of the 
antibiotic in each well, and the MIC is then set as the lowest concentration of antibiotics that 
produce no growth. The growth in the wells can be evaluated by visual inspection or by semi-
or fully automated systems. The advantages to this method over disc diffusion is quantitative 
values of the resistance (MIC values) and that it is easier to standardise and automatize (Kadlec 
et al., 2015).  
Spread of antibiotic resistance - What are the challenges and what is the extent 
of the problem? 
Drivers of antibiotic resistance in developing countries 
Reasons for antibiotic overuse and misuse in developing countries are many. Lack of 
knowledge by both “prescribers” (that may not be qualified in the first place) and by the users 
often results in faulty time of treatment or type of antibiotic. As laboratories of good standard 
are few, antimicrobial susceptibility patterns are usually unknown and leads to treatment based 
on empirical experience. Country-specific guidelines are often absent and continuing education 
programmes few. Opportunistic infections in people with severe malnutrition or HIV/AIDS, 
sometimes widely dispersed in these countries, may also increase the use (Okeke et al., 2005a; 
UNAS, 2015). 
Substandard quality of the antibiotics can also be a problem; they might be counterfeit, stored 
improperly or have passed their expiration date. Lower-than-stated doses cause suboptimal 
concentrations, which apart from causing therapeutic failure might result in selection of less 
drug-sensitive strains. A similar problem occurs when poor farmers sometimes cannot afford 
the prescribed full dose or treatment time-period. Economic factors also influence the 
prescribers, who sometimes even represent the manufacturers, and can cause excessive 
simultaneous use of multiple antibiotics, broad-spectrum antibiotics, high dosage and/or long 
treatment times (Okeke et al., 2005b; UNAS, 2015). 
Exposure to antibiotics by handling or ingesting milk-, egg- or meat-products is also present, 
since economic value of the products causes the farmers to ignore withdrawal periods (UNAS, 
2015). In a review by Darwish et al. (2013) the most commonly found antibiotic residues in 
food sold for human consumption in studies from eight African countries, Uganda not included, 
was tetracyclines and β-lactam antibiotics. In many cases, the residues exceeded the WHO 
limits (Darwish et al., 2013). A few reported frequencies of detectable penicillin in food 
products in African countries includes 14% of tested meat from a slaughterhouse in Nigeria 
(Ibrahim et al., 2009), 2% of farm bulk milk in Ethiopia (Abebew et al., 2014), 23% of locally 
produced beef in Egypt (Abdelrahman et al., 2017) and 14% of milk in milk collection centers 
in Kenya (Shitandi & Sternesjö, 2001). 
Besides the misuse of antimicrobials, the concurrent situation in many developing countries 
with shortfalls in the supply of clean water, vaccination coverage, sewage systems and safe 
food supplies increase the burden of infectious diseases that might need treatment with 
antibiotics (UNAS, 2015) and may also enable the spread of resistant microbes (Okeke et al., 
2005b). There are studies that suggest that transfer of MRSA between patients is more likely to 
occur in low-resource healthcare as compared to highly resourced hospitals (Price et al., 2014; 
Tong et al., 2015). Within the community, household subsistence farming is common in 
developing countries, and the close interaction between humans and animals likely increase the 
risk of transmission of any resistant organisms (Okeke et al., 2005b). Animals in communal 
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grazing systems are also closely interacting (Asiimwe et al., 2017b) and one study reported that 
the same individual milked separately owned cows on community grazing (Kateete et al., 
2014). 
Staphylococcal antibiotic resistance in Uganda 
Drug resistance is a prevalent and rapidly emerging problem in hospital settings in Uganda. In 
Mulago National Hospital, Kampala, SA accounted for 20.4% of 314 surgical site infections 
and out of these 37.5% were confirmed as MRSA by phenotype and by PCR targeting the mecA 
gene (Seni et al., 2013). In the same hospital, a screening for S. aureus on patients (wounds or 
nostrils), healthcare workers (hands or nostrils) and environment (frequently touched surfaces) 
showed that all 41 S. aureus-isolates (41% of 100 samples in total) were MRSA. Of these, 73% 
were PVL-positive and all (100%) had mecA and displayed oxacillin resistance (Kateete et al., 
2011). In Kiruhura, South-western Uganda, out of 253 screening nasal swab cultures, S. aureus 
was isolated in 73 (28.8%) swabs and out of these 48 (65.7%) samples were positive for mecA. 
PVL-encoding genes were present in 36 (49.3%) samples and 25 (34.2%) samples were positive 
for both PVL and mecA (Asiimwe et al., 2017a). Another screening of 499 rural in- and 
outpatients in the Mbarara Regional Referral Hospital for nasal carriage of MRSA by PCR 
(Cepheid Xpert SA Nasal Complete assay) found 2.8% of the samples to be positive, 
representing 9.7% of total S. aureus positives. Pig contact, open wounds and surgical ward 
admission was found to be associated with carriage (Bebell et al., 2016).  
Studies on staphylococci in Uganda using molecular typing methods are scarce in the veterinary 
sector. Asiimwe et al. (2017b) tested fresh bulk can milk in individual households in Kiruhura 
district, southwestern Uganda, which to their knowledge was the first study to demonstrate 
MRSA in raw milk in Uganda. After non-selective culturing on 5% sheep blood agar, S. aureus 
was isolated in 30/148 (20.3%) bulk can milk samples, of which 50% carried the mecA-gene 
and none carried mecC. When also including tested milk products (ghee and sour milk), 23/41 
(56.1%) carried the mecA gene, five were positive for lukS-PV or lukF-PV, and 90% had at least 
one gene coding for enterotoxins. Interestingly, only two strains had zones of inhibition ≤ 22 
mm for cefoxitin, making 21 strains of confirmed MRSA by mecA-carriage phenotypically 
sensitive to cefoxitin.  
Out of 163 isolates from non-selective aerobic culture, S. aureus was isolated from 27 (16.6%) 
samples, in a survey on subclinical mastitis including 124 dairy cattle from 12 farms in Kiboga 
district, central Uganda. The S. aureus was not tested for oxacillin or cefoxitin resistance, but 
all (100%) were highly resistant to penicillin and most also had resistance patterns for other 
antibiotics according to the Kirby-Bauer disk diffusion method (Kasozi et al., 2014). In Jinja 
district, eastern Uganda, coagulase-negative staphylococci was isolated in 30.5% and S. aureus 
was isolated in 11.9% of 688 quarter milk samples collected. Of all S. aureus and coagulase-
negative staphylococci isolated, 29.7% were resistant to oxacillin and 86.8% were resistant to 
penicillin according to the Kirby-Bauer disk diffusion method (Buyarugaba et al., 2008). An 
earlier MFS study on subclinical mastitis in the suburban region of Kampala isolated S. aureus 
in 8 (0.9%) of the samples, but out of these 50% were penicillinase producing (Abrahmsén et 
al., 2014). Yet another MFS study found that out of isolated CNS and S. aureus, 9 isolates 
(100%) from clinical mastitis, and 22 isolates (81%) from subclinical mastitis, were β-
lactamase producing. Of the nine S. aureus isolated, one had MIC ≥ 4 μg/mL for oxacillin and 
was thereby classified as an MRSA, one was not tested for oxacillin since it was negative for 
β-lactamase production, and resistance to cefoxitin was not evaluated in any of the isolates 
14 
 
(Björk, 2013). 
A study in The Kampala area comparing clinical mastitis isolates and their milkmens’ nasal 
isolates found coagulase-negative staphylococci resistant to both oxacillin and cefoxitin, 
interpreted as Methicillin resistance in both cows (12 of 21 isolated CNS, 57%) and humans (7 
of 11 isolated CNS, 64%). However, out of 58 included strains only one S. aureus was isolated 
from cows, and 4 out of 31 (13%) from nasal swabs. All five had the same spa-type and were 
sensitive to oxacillin and cefoxitin but differed in sensitivity patterns to other antibiotics. 
Consequently, transmission was deemed unlikely (Kateete et al., 2013). 
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MATERIAL AND METHODS 
Sample collection 
The proposal for the study was approved prior to commencement of the fieldwork by the 
Institutional Ethical Review Committee, College of Veterinary Medicine, Animal Resources 
and Biosecurity, Makerere University. An informed consent form was explained, signed and 
handed out to all animal owners or managers.  
Samples from milk collection centers 
26 samples from 21 milk collection centres were taken from various retailers in urban and 
suburban Kampala; some samples were collected repeatedly from the same retailers but on 
separate occasions and with several days in-between. The origin of the milk was recorded and 
only one sample sold in the same area and of similar origin was included per day, to decrease 
the risk of sampling milk from the same road-tanker. The milk was aspirated using sterile 10 cc 
syringes directly from the thin plastic bag that the milk is normally sold in, and transferred to a 
sterile test tube. The person aspirating was wearing disposable nitrile gloves disinfected with 
70% alcohol. The samples were kept in a cooling box with ice clamps during the transport to 
the laboratory. 
 
Figure 1. Map of Uganda, 
illustrating the total amount of 
cattle in each district, based on 
numbers from the 2008 national 
census (UBOS, 2010).  
Stars represent the stated origin 
(district) of the milk sampled 
from milk collection centres. 
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Cattle samples 
The local supervisors identified the farms selected for sampling, since local farmers only 
accepted my sampling in the company of their local veterinarian. However, efforts were made 
to scatter the locations to different areas and directions within 50 km of central Kampala. The 
total 16 farms included both large (15-55 animals) and small (2-5 animals) dairy farms. A 
majority of the farms were utilizing zero-grazing systems, but grazing and semi-grazing 
systems were also represented. A short questionnaire was performed to collect information on 
antibiotic usage and cattle history (see Appendix 1). 
Swab samples were taken using ESwab™ sterile swabs with Amies media (Copan, Bresca, 
Italy), from perineum and nasal mucosa in the ruminants. If restraint was needed for collection 
of the nasal swabs, it was usually achieved by firmly holding the horns. One of the swab sites 
was excluded in 11 (17%) of the cases, due to excessive resistance from the animal. The 66 
cows sampled were between 2.5-10 (mean 5.5) years of age and all were temperate (Friesian-
Holstein) breed or temperate-crossbreed (Friesian-Holstein cross with native breed). Four 
calves were also sampled, with nose-only or nose and perineal swabs. A median of 4.5 cows 
were sampled from each farm, ranging from 2 to 7 samples. 
Approximately 2-8 mL of milk from two to four teats was also collected from each cow. In the 
majority of cases, these were taken with the aid of the farmer who milked the cow while the 
sampler was catching the milk in a sterile sample tube. Some farmers washed the teats with 
water as a normal preparation before milking but no disinfectants were used. The farmers 
milking into the tube did not wear gloves but the sampler holding the tube was wearing 
disposable nitrile gloves that had also been disinfected with 70% alcohol. The samples were 
kept in a cooling box with ice clamps during the transport to the laboratory. 
Dog samples 
39 swabs for MRSP/MRSA screening in dogs were taken from patients seeking care in two 
animal clinics (13 samples from clinic A and 12 samples from clinic B), one rescue dog shelter 
(8 samples), two farms (3 samples) and three private homes (3 samples). Wearing disinfected 
gloves in an analogous manner, the dogs were swabbed on the nose and perineum using 
ESwab™ sterile swabs put in Amies media. A short questionnaire was performed to collect 
information on previous antibiotic treatment and illness history (see Appendix 2). 
Culturing and analyses 
A total of 96 samples from cattle and/or milk and 39 samples from dogs were included in the 
analyses. The methods used to determine carrier status were adapted from the methods currently 
employed by the Swedish National Veterinary Institute (SVA): 
Swabs and/or 0.8 mL of the milk sample were at the end of the day (or within 24 hours) mixed 
and transferred to 8 mL of selective enrichment broth. The cattle samples were pooled by means 
of adding both the milk and the swab from one individual to one tube with broth. Tryptic soy 
broth with 4% NaCl, 1% mannitol (SVA, Uppsala, Sweden) and 75 mg/L aztreonam added 
were used for both milk, cow and dog samples, but to allow growth of both MRSA and MRSP 
in the dog samples, the concentration of cefoxitin in the broth was calculated to 1 mg/L instead 
of 4mg/L. The broth was incubated at 37°C for 1-1.5 days. One negative control was set for 
every batch of broth. 
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The broth was vortexed, and 20 μL per plate was cultured on 5% bovine blood agar (SVA, 
Uppsala, Sweden) and chromogenic selective agar for MRSA (Oxoid BrillianceTM MRSA 2 
agar; Oxoid, Basingstoke, Great Britain). The dog samples were cultured on 5% bovine blood 
agar (SVA, Uppsala, Sweden) and Mannitol salt agar with LiCl (MAST agar; SVA, Uppsala, 
Sweden). The plates were incubated at 37°C, and growth was interpreted after 1 and 2 days. 
Suspected colonies were pure-cultured on 5% bovine blood agar plates and then assessed for 
haemolysis and Gram-stained. They were also tested with potassium hydroxide for distinction 
between Gram-positive and Gram-negative bacteria and catalase for distinction between 
streptococci and staphylococci. Isolates with β-, broad α-, or double haemolysis that were 
catalase-positive, potassium hydroxide-negative and microscopically were identified as cocci 
were frozen in BHI with 17% glycerol added (Oxoid, Basingstoke, Great Britain) until the end 
of the field work. Some phenotypically commonly occurring strains in the samples were also 
preserved for species-identification in Sweden. At the end of the fieldwork the isolates were 
again subcultured and shipped to Sweden in Amie’s media. 
In Sweden, the isolates were cultured on 5% bovine blood agar plates. All strains were species-
identified using MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) 
mass spectrometry (Bruker, Bremen, Germany). The strains that proved to be S. aureus or S. 
pseudintermedius were again sub-cultured and tested for antimicrobial susceptibility by 
determination of minimum inhibitory concentration (MIC) using VetMIC CLIN staph/strept 
panels (E 395129; SVA, Uppsala, Sweden) and cation-adjusted Mueller-Hinton broth (SVA, 
Uppsala, Sweden), a microdilution method, according to Clinical and Laboratory Standards 
Institute (CLSI; VET01/M100) standards. The control strain S. aureus ATCC 29213 was tested 
in parallel with the isolates. 
The isolates were classified as “susceptible” or “resistant” based on species-specific 
epidemiological cut-off values for each type of antibiotic, issued by the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST). For some antibiotics that were not listed 
by EUCAST, the cut-off values used in the annual Swedres-Svarm-report was used (Swedres-
Svarm, 2016). Staphylococcus aureus with MIC ≤ 2 μg/mL for cefoxitin and S. pseudinter-
medius with MIC ≤ 0.5 μg/mL for oxacillin were assayed for mecA, mecC and lukS-PV using 
Real-Time PCR following a protocol previously described (Pichon et al., 2012), using the S. 
aureus strains CCUG35601, CCUG60578 and CCUG63582 as controls. 
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RESULTS 
Samples from milk collection centers 
Of the 26 samples from milk collection centres, S. aureus were isolated from five samples, 
corresponding to 19.2% of all samples in this category. One sample was identified as MRSA 
by phenotype (representing 3.8% of all samples in this category) but was negative for mecA and 
mecC (Table 2 no. 8). This isolate was also positive for PVL-toxin and resistant to tetracycline. 
The other four samples had a MIC of 4 μg/mL for cefoxitin and all were negative for mecA, 
mecC and lukS-PV (see Table 2). 
An additional six samples from milk collection centres were tested without the broth-
enrichment step. The samples were originally excluded since they were collected from retailers 
that stated the same region of origin of the milk (Mbarara), but the next day 20 μL of milk from 
each sample was streaked directly on 5% bovine blood agar (SVA, Uppsala, Sweden). One 
sample was suspected and later proven to grow S. aureus (Table 2, No. 15). 
Table 2. Distribution of MIC values (μg/ml) among the S. aureus isolates. None of the 15 isolates 
expressed resistance towards enrofloxacin, fusidic acid, clindamycin, gentamicin or nitrofurantoine. 
Isolates no 1-4 originating from cows, No.s 5-9 originating from milk collection centres, no. 10 
originating from a dog in clinic B, No.s 11-12 originating from dogs in the shelter, No.s 13-14 from 
dogs at a farm and no 15 from a milk collection centre without broth enrichment. Abbreviations: Pen= 
penicillin; Cet= cefalotin; Oxa= oxacillin; Fox= cefoxitin; Ery= erythromycin; Tet= tetracycline; Tsu= 
trimethoprim-sulfonamide 
Isolate no. Pen Cet Oxa Fox Ery Tet Tsu PCR 
1 >1 <1 1 4 1 0.5 0.5/9.5 PVL-pos. 
2 >1 <1 0.5 4 <0.5 0.5 >4/76 PVL-pos. 
3 >1 <1 >1 4 <0.5 0.5 0.5/9.5 PVL-pos. 
4 >1 <1 <0.25 4 <0.5 >4 <0.25/4.75 Neg. 
5 >1 <1 1 4 <0.5 >4 <0.25/4.75 Neg. 
6 >1 <1 >1 4 <0.5 >4 <0.25/4.75 Neg. 
7 0.06 <1 0.5 4 <0.5 0.5 <0.25/4.75 Neg. 
8 >1 2 >1 >8 <0.5 >4 0.5/9,5 PVL-pos. 
9 >1 <1 0.5 4 <0.5 >4 <0.25/4.75 Neg. 
10 >1 <1 1 4 <0.5 0.5 >4/76 PVL-pos. 
11 >1 <1 <0.25 4 <0.5 <0.25 <0.25/4.75 Neg. 
12 <0.03 <1 <0.25 2 1 0.5 <0.25/4.75 Neg. 
13 >1 <1 <0.25 2 <0.5 1 <0.25/4.75 Neg. 
14 >1 <1 <0.25 2 <0.5 0.5 <0.25/4.75 Neg. 
15 >1 <1 <0.25 2 <0.5 <0.25 <0.25/4.75 PVL-pos. 
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Cattle samples 
In total, cows from 16 farms and households were sampled. The results from the questionnaire 
indicated that most farmers had used antibiotics historically. Five farmers stated that they used 
intramammal dry-cow therapy for all cows and six farmers perceived mastitis to be a 
reoccurring problem in their herd. During the withdrawal periods, most farmers fed the milk to 
the calves, pigs or dogs. Only two farmers stated to sometimes discard the milk, and two 
admitted that the milk sometimes was drunk by humans or even sold. Most farmers stated that 
their milkers washed their hands before but not after the milking. All cows were manually 
milked and about one out of four had problems with sores on the teats. Two farms stated that 
the milkers also worked on other farms, two cows sometimes used community grazing. All but 
one farm stated that the buyers come to the farm and the cows are not brought to the market. 
All respondents answered that the veterinarian prescribed the drugs used. 
The cows’ history of mastitis was not always known, but a third of the cows were stated to have 
a history of mastitis and in three cows, the mastitis was perceived as recurring. Four farmers 
used a combination of procaine penicillin, streptomycin sulphate, neomycin sulphate and 
prednisolon (Multiject IMM, Norbrook, Great Britain), intramammary suspension, as a 
standard treatment for clinical mastitis. Dry cow therapy for all cows with cloxacillin was 
reported by three farmers. Four farmers stated previous use of tetracycline and/or gentamycin 
and eight reported previous use of penicillin with or without streptomycin. 
Four S. aureus-isolates were found in samples from three cows (4.5% of all samples in this 
category) and all had a MIC of 4 μg/mL for cefoxitin. One of the tested animals appeared to 
have two S. aureus strains (Table 2, No.s 2 and 3), both displaying cefoxitin resistance of 4 
μg/mL but with distinctly different phenotypical appearance on the plate, and displaying 
differing resistances towards oxacillin and trimethoprim/sulphadiazin. The isolate depicted as 
number one (Table 2), was isolated from a cow kept at a separate location but with the same 
owner as No.s 2 and 3. All three isolates from that farm were PVL-positive (Table 2, No.s 1, 2, 
and 3). 
Dog samples 
Out of 39 dog samples S. aureus grew in five samples (Table 2, No.s 10-14), representing 12.8% 
of all samples in this category. Among the five S. aureus- strains isolated from dogs, one strain 
was from clinic B, two were from the shelter-dogs and two were from a farm. Out of 10 samples 
that initially grew S. pseudintermedius (25.6% of all samples in this category, see Table 3) none 
showed any resistance to oxacillin and therefore none was included for PCR. However, three 
S. pseudintermedius strains had a MIC of 2 μg/mL for erythromycin and clindamycin and five 
strains had a MIC of > 4 μg/mL for tetracycline. One strain, from clinic A, showed resistance 
towards almost all tested antibiotics except the β-lactams; enrofloxacin, erythromycin, 
clindamycin, gentamicin, tetracycline, trimethoprim and sulphadiazin (Table 3, No. 2). 
From the questionnaires, the median age of the dogs sampled (excluding 11 with unknown age) 
was 2 years, ranging from 2 months to 14 years. One third of the dogs (13/39) had been treated 
with antibiotics in the last 6 months. Out of the dogs with isolated S. pseudintermedius, six 
(60%) had been treated with antibiotics in the last 6 months (Table 3, No.s 2, 3, 4, 6, 7 and 10). 
No treatment failures were perceived, and the most commonly used antibiotics were penicillin-
streptomycin and metronidazole. Three dogs had a history of dermatitis and of these, one grew 
haemolytic staphylococci that proved to be S. pseudintermedius (Table 3, No. 6). No dogs 
except for the shelter dogs were kept in a kennel with other dogs. None of the dogs with isolated 
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S. aureus had been treated with antibiotics, but the shelter dogs lived in close proximity and 
were treated with antibiotics after spaying that occurred regularly. The answers regarding 
prescribers of the antibiotics and whether anyone in the family worked with animals or 
healthcare was mostly not recorded, hence these results are not presented. 
Table 3. Distribution of MIC values (μg/mL) among the S. pseudintermedius isolated. None of the 10 
isolates expressed MIC <0.5 μg/mL for fusidic acid or <16 μg/mL for nitrofurantoine. No.s 2-5 
originated from clinic A, No.s 6-10 from clinic B, and isolate no 1 from a farm. Abbreviations: Pen= 
penicillin; Cet= cefalotin; Oxa= oxacillin; Fox= cefoxitin; Enr= enrofloxacin; Ery= erythromycin; 
Cli= clindamycin; Gen= gentamicin; Tet= tetracycline; Tsu= trimethoprim-sulfonamide  
 
Isolate Pen Cet Oxa Fox Enr Ery Cli Gen Tet Tsu 
1 1 <1 <0.25 <0.25 0.5 >2 >2 <1 >4 0.5/9.5 
2 0.25 <1 <0.25 <0.25 1 >2 >2 >4 >4 >4/76 
3 0.5 <1 <0.25 <0.25 <0.25 <0.5 <0.5 <1 >4 >4/76 
4 <0.03 <1 <0.25 <0.25 <0.25 <0.5 <0.5 <1 <0.25 0.5/9.5 
5 <0.03 <1 <0.25 0.5 <0.25 <0.5 <0.5 <1 <0.25 0.5/9.5 
6 >1 <1 <0.25 <0.25 0.5 >2 >2 <1 >4 0.5/9.5 
7 >1 <1 <0.25 0.5 <0.25 <0.5 <0.5 <1 >4 1/19 
8 <0.03 <1 <0.25 <0.25 <0.25 <0.5 <0.5 <1 <0.25 
<0.25/ 
4.75 
9 0.5 <1 <0.25 <0.25 <0.25 <0.5 <0.5 <1 <0.25 0.5/9.5 
10 >1 <1 <0.25 <0.25 <0.25 <0.5 <0.5 <1 >4 1/19 
 
Profuse growth of bacterial and sometimes fungal species was found in most samples, including 
various kinds of bacilli, yeast and/or mold. All samples appeared to have at least two species 
of bacteria growing on the blood agar plates, and only a few samples had a single species 
growing on the selective BrillianceTM-agar plates. Fourteen isolates that were not included in 
the results were transported to Sweden. Three were inconclusive or suspected on the tests in 
Uganda, and the rest were brought out of interest or as examples, of which four were non-
haemolysing staphylococci. Species identified by MALDI-TOF included Macrococcus 
caseolyticus, Enterococcus faecalis, Aerococcus viridans, Staphylococcus sciuri, Staphylo-
coccus schleiferi and Staphylococcus epidermidis. These were not tested for antibiotic 
susceptibility or for mec/luk -genes. 
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DISCUSSION 
Samples from milk collection centers 
With only one isolated MRSA (Table 2, No. 8), any predisposing factors or common variables 
are impossible to determine. The milk from which the MRSA was isolated had a stated origin 
of Nyabushozi, South-western Uganda. On two subsequent samplings within eight days from 
the same shop, S. aureus was not found. This is encouraging and could indicate that the bacteria 
did not persist and perhaps successfully were removed during cleaning of the tank. Possibly, it 
could also have been picked up from the hands of the retailer on the day of the first sampling.  
A MIC of > 4 μg/L for cefoxitin in S. aureus is mostly due to the presence of mecA or mecC 
(EUCAST, 2018), so it is notable that the MRSA-isolate (Table 2, No. 8) appeared not to carry 
these genes. Further analyses to determine the cause of the high-level resistance towards β-
lactams in the MRSA-isolate would be very relevant and interesting, preferably using whole-
genome sequencing. This would illustrate any mutations that might have affected the primer 
attachment-sites and therefore prevented amplification or could detect the presence of other 
mec-genes (Hill-Cawthorne et al., 2014). As M. caseolyticus recently has been proved to carry 
and have the ability to transfer a mecB-element to S. aureus (Tsubakishita et al., 2010; 
Schwendener et al., 2017; Becker et al., 2018), analysis for carriage of mecB might prove 
relevant, but is much less informative than whole-genome sequencing. The microdilution-array 
for the MRSA-isolate was however only done once, so an advisable first step would be to repeat 
the test to confirm the MIC-value. 
The microdilution-array used in this study limited the determination of exact MIC values for 
all β-lactams concerning the MRSA strain isolated (Table 2, No. 8), except the MIC for 
cefalotin. As a comparison, confirmed MRSA-isolates with the same MIC (2 μg/L) for cefalotin 
as the isolate in this study, collected from animals in Sweden between 2006-2016, had MIC 
values of > 16 μg/mL for cefoxitin in 80% of the cases (range 8 to > 16), and MIC values of > 
16 μg/mL for oxacillin in 60% of the cases (range 1 to > 16) (Swedres-Svarm, 2016). The 
recently described mecB-carrying MRSA UKM4229 also had a MIC value for cefalotin of 2 
μg/L, and its MIC was 32 μg/mL for cefoxitin and 12 μg/mL for oxacillin (Becker et al., 2018). 
It is possible that the isolate found in this study had comparable MIC values for cefoxitin and 
oxacillin. It was the only strain isolated that displayed resistance towards cefalotin.  
The total percentage of milk samples from which S. aureus was isolated (19.2%) correlates well 
with the recent results of Asiimwe et al. (2017b; 20.3%). This study also reports that out of 23 
mecA-positive Ugandan isolates from milk samples, only two were phenotypically resistant to 
cefoxitin according to EUCAST definitions. These two isolates were also resistant to oxacillin; 
the resistance status to oxacillin regarding the remaining isolates was however not accounted 
for. This could otherwise have been an interesting comparison since among the S. aureus 
isolated in this study, a variance in susceptibility to oxacillin between < 0.25 to > 1 μg/mL was 
noted in the strains with MIC 4 μg/mL for cefoxitin. The results of Asiimwe et al. (2017b) also 
implies that the method used in this study, with added antibiotics to the enrichment broth, could 
mean S. aureus that were not expressing their mec-genes were not found. All S. aureus-isolates 
in the present study were negative for the mecA and mecC genes, however six (including the 
single MRSA isolate, Table 2, No. 8) were positive for lukS-PV, a gene that possibly can 
potentiate the bacterium in the early stages of infection (Voyich et al., 2006). All S. aureus 
isolates in this study showed some resistance to β-lactams, which in theory can affect the 
outcome of clinical treatment. 
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The scope of the study did not allow analysis of all staphylococcus-species found, even if some 
are known to be able to carry mec-genes (Couto et al., 1996; Wu et al., 2001; Monecke et al., 
2012) that have been suspected to have been transferred to S. aureus (Wielders et al., 2001; 
Méric et al., 2015). The absolute majority of milk and cow samples appeared to grow coagulase-
negative staphylococci (and Macrococcus caseolyticus), including the samples that also grew 
S. aureus. In future studies, it would be relevant to analyse most of the staphylococci that appear 
to be able to grow in the selective antibiotic broth, because of their pathogenic potential to 
humans and cattle (Piette & Verschraegen, 2009; Björk, 2013; Buyarugaba et al., 2008) but 
also for indications of possible transfer of mec-genes.  
Cattle samples 
The farmers were not asked to wear gloves or wash the teats with disinfectants/alcohol before 
sampling. Further, milk samples and swab samples from the same individual were pooled. This 
procedure was chosen since any MRSA found on the outside of the teat, on the nose or 
perineum, or on the milkers’ hands means that it is present in the cows’ immediate surroundings 
and are posing the cow at risk for infection. As anticipated, S. aureus did still not appear to be 
common in the samples.  
The sample groups were not randomly selected, and the farms selected were dependent upon 
previous contacts with veterinarians, a bias that can be claimed to both favour and oppose the 
results in this study, since the system in Uganda does not exclusively limit the usage of 
antibiotics to veterinarians. Antibiotic usage could be favoured, since they have contact with a 
veterinarian that might observe disease and recommend therapy, or it could be causing a more 
directed or appropriate usage and thereby result in lower usage than a farmer without guidance 
would have. The sample group was also heavily biased towards exotic or crossbreed exotic 
cows, kept in intense systems. According to the questionnaire, most cows had limited direct 
and indirect contact with other cattle, which could decrease the risk of transmission of disease 
and bacteria.  
A few individual responses might also be mentioned. For example, one farmer stated that they 
treated cows with suspected ECF with tetracycline just to get the fever down, and one treated 
all cows with penicillin-streptomycin the first few days after giving birth. Many farmers did not 
seem to know the difference between antibiotics and other drugs, and to make sure to not miss 
anything, all drugs were listed, including vaccinations and deworming. It was generally hard to 
establish the timeline of when the treatments had taken place, so except for in a few cases when 
it was recent, the treatments they usually used or had used in the past were noted. Hence records 
of individual treatments were too vague to produce any statistics. 
It was observed that most milkmen used a poor milking technique, pulling the teats instead of 
squeezing them, an observation that has been made in earlier studies (Kateete et al., 2013). As 
earlier mentioned, around one out of four cows had problems with sores on the teats, which 
according to local veterinarians is a common side effect of this milking technique. To prevent 
these sores, some farmers used Norbrook Milking Salve (Noorbrook, Nairobi, Kenya) with 
0.55% w/w Dichlorophen BP. Dichlorophen is a biocide that has been used as a veterinary 
anticestodal drug, and has antifungal, antiprotozoal and antibacterial activity (Aronson, 2016). 
From observations made during the study, it was highly likely to contaminate the milk during 
milking.  
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If, despite the milking salve, the sores get infected they can serve as a reservoir and cause spread 
of the bacteria to other milking cows. Even in the absence of clinical signs of infection, damage 
in the skins’ natural barrier will provide a favourable environment for bacteria. 
Dog samples 
The sample group was probably biased towards dogs that had been treated with antibiotics since 
most dogs were sampled at veterinary clinics and a third of the dogs had been treated in the last 
six months. Since no numbers are available on antibiotic consumption for the species in 
Uganda, this can however not be verified. The proportion of treated dogs seemed to be higher 
(6 of 10) in the group where S. pseudintermedius could be detected, as compared with dogs 
where S. pseudintermedius could not be isolated (7 of 29). If the sample had been larger this 
difference would have been interesting to test for statistical significance. There also seemed to 
exist an association between antibiotic treatment in the last six months and the dogs carrying S. 
pseudintermedius displaying resistance to more than one antibiotic, since all but one of these 
were isolated from dogs that had a history of antibiotic treatment. Since the kind(s) of 
antibiotic(s) used were not always specified and the sample size was very small, the relevance 
of these findings is unclear. It is however established that antibiotic use promotes antibiotic 
resistance and sometimes genes for resistance to different antibiotic groups are linked (Knight 
et al., 2012; Perreten et al., 2010; Bal et al., 2016) so it is possible that the connection would 
still be found in a larger sample group.  
The exception was the dog from the farm, from which both S. pseudintermedius (Table 3, No. 
1) and S. aureus (Table 2, No. 14) were detected and it lived on a farm where S. aureus was 
isolated from a cattle-sample (Table 2, No. 4). Another dog was sampled there, and S. aureus 
was isolated (Table 2, No. 13) from the swab. Both S. aureus- isolates from the dogs were 
susceptible upon microdilution in Sweden (2 μg/mL for cefoxitin). These results might still 
suggest transfer of antibiotic resistance, although then more likely of β-lactamases and 
tetracycline resistance. A third sample from a dog on that farm was unfortunately unaccounted 
for upon arrival to Sweden, but all three samples grew haemolytic staphylococci. This was the 
only sample that was unaccounted for.  
Since cefoxitin resistance is not considered predictive for Methicillin-resistance in S. 
pseudintermedius (EUCAST, 2018), the inclusion of this antibiotic in the enrichment broth used 
for cultivation of the dog samples could have negatively affected the number of samples where 
S. pseudintermedius could be detected. For safety reasons, the oral mucosa was not sampled, 
which also could have affected the results since it is one of the most common carrier sites 
(Bannoehr & Guardabassi, 2012). 
The dogs could easily be colonised with environmental flora since dogs tend to sniff their 
surroundings and the strains that were obtained could have been picked up upon arriving, or 
even from the samplers. Even if measures were taken to collect the swabs as soon as possible 
at arrival to the clinic, this was not always the case.  
Confounding factors and observations 
Sampling and analyses of bacteria in a developing country is a challenge to overcome, from the 
hardships with translation to the occasionally malfunctioning equipment and lack of electricity. 
The questionnaires were interpreted and conveyed by the same person on all occasions, but the 
answers still sometimes seemed a bit lost in translation. Not all questions were answered 
satisfactory, and some answers were excluded when it was suspected that the respondent had 
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misinterpreted them. Still, the response frequency to the questions that have declared results 
was over 85%, with some exceptions already mentioned. The presence of both the researchers 
and the local veterinarian might also have been influencing the answers. 
The incubators had backup-electricity and were to our knowledge not affected by any power 
failures. However, in the cultivation of approximately the 20 first samples (from individual 
cattle), growth was slower than anticipated. This was amended when an incubator that was not 
opened as frequently was designated for this study, but the first samples were thus given less 
opportunity to grow in the broth, a possible source of error. The rest of the samples were 
incubated approximately 1-1.5 days and all plates were also evaluated after 2 days to ensure 
nothing was missed because of decreased speed of growth.  
Notably, two strains of S. aureus displayed almost no resistance towards penicillin and still had 
a MIC of 2-4 μg/mL for cefoxitin (Table 2, No.s 7 and 12). β-lactamases that have a higher 
affinity towards cefoxitin than penicillin do exist, however they are very rare (Bush et al., 1995) 
and the results might be faulty despite repeated analysis.  
The colour and appearance of the suspected MRSA on the Brilliance-plates mostly did not 
appear typical, none of the isolated S.aureus were found through their appearance on the 
brilliance plates. This might be because none turned out to carry mecA or mecC, although the 
no. 8 (Table 2) and no. 1 (Table 2) did grow in an anticipated manner for MRSA on the 
Brilliance-agar, when subcultured from the suspected colonies found on the blood agar plates. 
Since all suspected staphylococci with haemolysis were included, this would not have affected 
the results, but streaking all samples on the brilliance plates seemed an unnecessary procedure.  
Suspected contaminating colonies were isolated from a total of five samples. Upon resistance 
testing, they all had the same antibiotic resistance pattern as an example strain for MRSA that 
had been isolated in the Ugandan lab from a dog with an infected wound, prior to the 
commencement of this study. The five samples included three samples that were originally 
shipped to Sweden as example strains of non-haemolytic coagulase-negative staphylococci but 
were contaminated with S. aureus upon culturing in Sweden, and secondly, two isolates that 
were identified as contaminations in Uganda since they were found out of streak, and were 
brought for analysis in Sweden out of curiosity. These isolates had a MIC > 1 μg/mL for 
oxacillin and penicillin, 8 μg/mL for cefoxitin, > 1 μg/mL for enrofloxacin, > 2 μg/mL for 
erythromycin and > 4 μg/mL for gentamicin. They were sensitive to the other antibiotics tested. 
The MRSA example strain was negative for mecA, mecC and PVL-toxin. The occurrence of 
this identical antibiotic resistance pattern on multiple contaminants of the samples is suggestive 
of a lab-borne contagion. However, none of the other antibiotic resistance patterns clearly 
suggested a common origin for the rest of the samples.  
Three of the samples from milk collection centres (Table 2, No.s 6, 7 and 9) derived S. aureus 
from just one colony with clear haemolysis in the primary streak. This might be explained by 
their MIC for cefoxitin, which was the same concentration (4 μg/ml) as the broth used in 
Uganda. The bacteria supposedly were able to survive but not to reproduce, making the amount 
of S. aureus scarce in the broth and thus rendering colonies only appearing in the primary streak. 
The massive growth of other bacteria in the broth could also have inhibited growth due to 
shortage of substrate. Most of the milk and cow samples had large pellets of bacteria at the 
bottom of the tubes by the time they were to be streaked on the agar plates. Another explanation 
would be that the primary streak was contaminated after streaking of the sample. 
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Final comments 
The risk of transfer of staphylococci to humans from animals and vice versa is well documented 
(van Loo et al., 2007; Weese & van Duijkeren, 2010; Soedarmanto et al., 2011). The situation 
in Uganda with poor milking hygiene (Byarugaba, 2008; Kateete et al., 2013), high frequency 
of (SCM) mastitis (Abrahmsén et al., 2014; Björk et al., 2014), poorly controlled use of 
antibiotics (Mukonzo et al., 2013) and sale and distribution of unprocessed raw milk (Grimaud 
et al., 2009) leaves both humans and animals exposed to possible future spread of and disease 
caused by resistant bacteria. This spread is already evident in some hospital settings in Uganda 
(Ojulong et al., 2009; Kateete et al., 2011; Seni et al., 2013). With molecular characterization 
of strains of animal origin largely lacking, the relevance of animals as potential reservoirs 
cannot be assessed. More studies are needed and awareness of the problem among the public 
needs to increase. From the results in this study, sampling of unprocessed bulk milk seems a 
cost-efficient way to obtain a broad perspective on the prevalence of antibiotic resistance in the 
dairy industry in Uganda and is a very relevant direction for future studies. The presence of 
methicillin resistance seemed low in this study but resistance to other antibiotics and among 
other bacterial species seemed more commonplace. However, the sample size was small and 
the biases many, so further studies are needed to make any statements about antibiotic resistance 
in Kampala or Uganda. 
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APPENDIX 1 
Questionnaire for large and small dairy units   Sample number: 
     Date: 
General questions about the herd: 
Herd is:  Grazing/Semi-grazing/community grazing/tethering/zero grazing  
1. Have your cattle been treated with medicine in the last six months? With what?  
Do you use any regular treatments with antibiotics? 
2. Who decided which drugs to be used?   Owner/manager/local vet/pharmacist 
3. What happens to the milk during withdrawal period?  Sold/fed to the 
animals/humans drink/poured away 
4. Do you think mastitis is common on your cow(s), for the last year(s)?   YES/NO/Unsure  
5. Do you think your herd has problems with recurring mastitis?   YES/NO/Unsure  
6. Do you wash your hands before    Often/Sometimes/Rarely 
and/or after milking?   Often/Sometimes/Rarely 
7. Do you use dry cow therapy? Is this on every animal, or only those that has had mastitis? 
8. Are the cows sold at the market? If not sold, are they released back into the herd? 
9. Do the milkers work on other farms as well?  YES/NO/Unsure 
10. Do you want to know the preliminary results?   YES/NO 
Questions about the individual cow(s):  Age?   
11. Has this cow been treated with medicine? Within the last three months or before that? 
12. With what? 
13. Did it respond, or did you have to change treatment? Using which drug? YES/NO/Unsure 
14. Does this cow have a history of mastitis?  YES/NO/Unsure 
15. Has it had mastitis several times?   YES/NO/Unsure 
Notes on site and manor of sample collection: 
 
  
2 
 
APPENDIX 2 
Questionnaire for dog owners    Sample number: 
       Date: 
 
1. Age of the dog?  
 
2. Has your dog been treated with antibiotics, for example for a wound, in the last six months? Do you 
remember the name of the product?  
 
3. … If so, who prescribed/provided it for you?          Owner/manager/local vet/pharmacist 
 
4. Did it respond, or did you have to change treatment? Using which antibiotic? 
 
 
5. Has your dog shared kennel or household with another dog that was treated with antibiotics, the last 
six months? Do you know with what? 
 
 
6. Has your dog or anyone in its surroundings had problems with wounds not healing? 
 
… or dermatitis?    YES/NO/Unsure 
 
7. Does anyone in the family work in a hospital/care facility? YES/NO/Unsure 
 
8. Does anyone in the family work with animals?  YES/NO/Unsure 
 
9. Do you want to know the preliminary results?   YES/NO 
 
Notes on site and manor of sample collection: 
 
